For a low‑risk adult patient without gastrointestinal ulcer disease, cardiovascular disease, renal impairment, or NSAID allergy, which medication—ketorolac or diclofenac—is more appropriate for short‑term moderate‑to‑severe acute pain?

Ketorolac vs Diclofenac for Short-Term Acute Pain

For a low-risk adult patient requiring short-term management of moderate-to-severe acute pain, either ketorolac or diclofenac is appropriate, but ketorolac should be strictly limited to ≤5 days while diclofenac may be used for longer durations if needed.

Key Regulatory Distinctions

The FDA labeling provides critical guidance that differentiates these agents:

• Ketorolac is specifically indicated for short-term (≤5 days) management of moderately severe acute pain requiring opioid-level analgesia, typically in postoperative settings 1
• Diclofenac is indicated for mild-to-moderate pain without the strict 5-day limitation, though shortest duration principles apply 2

Both carry identical black-box warnings for cardiovascular thrombotic events and gastrointestinal bleeding 3.

Clinical Efficacy Evidence

The drugs demonstrate equivalent analgesic efficacy across multiple pain conditions:

• In renal colic, ketorolac 30 mg IM and diclofenac 75 mg IM showed no significant difference in pain relief, rescue medication requirements, or adverse effects 4
• After orthopedic surgery, intravenous diclofenac (HPβCD formulation) actually demonstrated superior pain relief compared to ketorolac, with faster onset and significantly lower opioid requirements (P<0.008) 5
• A large European safety trial of 11,245 patients after major surgery found ketorolac, diclofenac, and ketoprofen equally safe, with identical rates of serious adverse outcomes including death (0.17%), surgical site bleeding (1.04%), and renal failure (0.09%) 6

Practical Prescribing Algorithm

Choose ketorolac when:

• Pain is severe enough to otherwise require opioids
• Treatment duration will definitively be ≤5 days
• Parenteral administration is preferred initially
• Patient is in immediate postoperative period

Choose diclofenac when:

• Pain is mild-to-moderate
• Treatment may extend beyond 5 days
• Oral administration is acceptable from the start
• Patient has chronic inflammatory conditions (osteoarthritis, rheumatoid arthritis)

Dosing Specifications

Ketorolac: 15-30 mg IV every 6 hours, maximum 5 days total duration (parenteral + oral combined) 7, 1

Diclofenac: Standard oral dosing without the strict 5-day limitation, though use shortest effective duration 2

Critical Safety Considerations

Both agents share identical risk profiles in your low-risk patient 6:

• Gastrointestinal toxicity: Both increase ulceration/bleeding risk equally. Consider prophylactic PPI if treatment extends beyond a few days, though PPIs only protect upper GI tract 8
• Cardiovascular risk: Diclofenac may carry slightly higher CV risk than other NSAIDs based on registry data (RR 1.63 for vascular events vs placebo) 3
• Renal effects: Monitor if treatment extends beyond 3-5 days; both equally nephrotoxic 7, 9
• Surgical bleeding: Postoperative anticoagulants increase bleeding risk equally with both agents (OR ~2.6-3.6) 6

Common Pitfalls to Avoid

1. Never exceed 5 days total ketorolac use (IV + oral combined) - this is an FDA-mandated hard stop due to escalating toxicity 1
2. Don't assume ketorolac is "stronger" - evidence shows equivalent or sometimes inferior efficacy to diclofenac 5, 4
3. Avoid in patients ≥60 years without careful risk assessment - both guidelines emphasize age as a major risk factor for GI/renal toxicity 7, 9
4. Don't use either agent perioperatively for CABG surgery - both are contraindicated 3

Special Population Note

In elderly patients (≥65 years) after orthopedic surgery, diclofenac demonstrated significantly better analgesic efficacy and lower opioid requirements compared to ketorolac 5, suggesting diclofenac may be preferable in older adults when NSAIDs are deemed necessary.